Sertraline-associated syndrome of inappropriate antidiuretic hormone: Case report and review of the literature

Pharmacotherapy

Volumn 16, Issue 4, 1996, Pages 680-683

  Bradley, Mary E ^a   Foote, Edward F ^a   Lee, Edwin N ^b   Merkle, Larry ^b  

^a RUTGERS UNIVERSITY   (United States)

^b LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEMECLOCYCLINE; SERTRALINE; VASOPRESSIN;

ABDOMINAL AORTA ANEURYSM; ADJUVANT DISEASE; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEHYDRATION; DEPRESSION; FEMALE; HUMAN; HYPONATREMIA; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; SODIUM EXCRETION; VASOPRESSIN RELEASE;

1-NAPHTHYLAMINE; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; INAPPROPRIATE ADH SYNDROME; SERTRALINE; VASOPRESSINS;

EID: 0029798715     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Moses AM, Streeten DH. Disorders of the neurohypophysis. In: Isselbacher KJ, Braunwald E, Wilson JD, et al, eds. Harrison's principles of internal medicine, 13th ed. New York: McGraw-Hill, 1994:1921-30.
2. Kovacs L, Robertson GL. Syndrome of inappropriate antidiuresis. Endocrinol Metab Clin North Am 1992;21: 859-75.
3. Votey SR, Peters AL, Hoffman JR. Disorders of water metabolism: hyponatremia and hypernatremia. Emerg Med Clin North Am 1989;7:749-69.
4. Riggs AT, Dysken MW, Kim SW, Opsahl JA. A review of disorders of water homeostasis in psychiatric patients. Psychosomatics 1991;32:133-48.
5. Benazzi F, Bartolini F, Mazzoli M. Medical complications of polydipsia in nonpsychotic depression. Can J Psychiatry 1994;39:185.
6. Gommans JH, Edwards RA. Fluoxetine and hyponatremia [letter]. N Z Med J 1990;103:106.
7. Hwang AS, Magraw RM. Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine [letter]. Am J Psychiatry 1989;146:399.
8. Cohen BJ, Mahelsky M, Adler L. More cases of SIADH with fluoxetine [letter]. Am J Psychiatry 1990;147:948-9.
9. Staab JP, Yerkes SH, Cheney EM, Clayton AH. Transient SIADH associated with fluoxetine [letter]. Am J Psychiatry 1990;147:1569-70.
10. Viswanath BM, Navalgund AA, Cusano W, Navalgund KA. Fluoxetine as a cause of SIADH [letter]. Am J Psychiatry 1991;148:542-3.
11. Kazal LA, Hall DL, Miller LG, Noel ML. Fluoxetine-induced SIADH: a geriatric occurrence? J Fam Pract 1993;36:341-3.
12. Blacksten JV, Birt JA. Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine. Ann Pharmacother 1993;27:723-4.
13. Marik PE, van Heerden W, Steenkamp V. Fluoxetine-induced syndrome of inappropriate antidiuretic hormone excretion. S Afr Med J 1990;78:750-1.
14. Chau TP, Vong SK. Hyponatremia associated with paroxetine [letter]. BMJ 1993;306:143.
15. Goddard C, Paton C. Hyponatremia associated with paroxetine [letter]. BMJ 1992;305:1332.
16. Crews JR, Potts NL, Schreiber J, Lipper S. Hyponatremia in a patient treated with sertraline. Am J Psychiatry 1993;150:1564.
17. Doshi D, Borison R. Association of transient SIADH with sertraline. Am J Psychiatry 1994;151:779-80.
18. Dyball RE. The effects of drugs on the release of vasopressin. Br J Pharmacol 1968;33:329-41.
19. Budavari S, O'Neil MJ, Smith A, Heckelman PE, eds. The Merck index. Rahway, NJ: Merck & Co., 1989.
20. Kendler KS, Weitzman RE, Rubin RT. Lack of arginine vasopressin response to central dopamine blockade in normal adults. J Clin Endocrinol Metab 1978;47:204-7.
21. Brownfield MS, Greathouse J, Lorens SA, et al. Neuropharmacological characterization of serotonergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology 1988;47:277-83.
22. Pergola PE, Sved AF, Voogt JL, Alper RH. Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin. Neuroendocrinology 1993;57:550-8.
23. Gibbs DM, Vale W. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into the hypophysial portal blood. Brain Res 1983;280:176-9.
24. Faull CM, Rooke P, Baylis PH. The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man. Clin Endocrinol 1991;35:423-30.